Alterations in focal adhesion and cytoskeletal proteins during apoptosis

Area of Science:

• Cell Biology
• Apoptosis Research
• Cancer Cell Signaling

Background:

• Ceramide is known to induce cell rounding and apoptotic cell death.
• Protein tyrosine phosphatase inhibitors (e.g., orthovanadate) and serine/threonine phosphatase inhibitors (e.g., calyculin A) modulate these ceramide-induced effects.
• Understanding the molecular mechanisms linking cell rounding to apoptosis is crucial.

Purpose of the Study:

• To investigate critical cellular changes, specifically focal adhesion and cytoskeletal proteins, during ceramide-induced cell rounding and apoptosis.
• To compare protein alterations in apoptotic round cells, non-apoptotic round cells, and adherent cells.

Main Methods:

• Immunoblotting was used to examine focal adhesion and cytoskeletal proteins.
• Cells treated with ceramide, orthovanadate, and calyculin A were analyzed.
• Comparisons were made between apoptotic round cells, non-apoptotic round cells, and adherent cells.

Main Results:

• Tyrosine phosphorylation of proteins (110-125 KDa), including focal adhesion kinase (FAK), decreased in apoptotic round cells and non-apoptotic round cells induced by calyculin A.
• A significant decrease in vinculin, paxillin, and FAK occurred specifically in apoptotic round cells, preceding broader cellular protein changes.
• Orthovanadate inhibited ceramide-induced apoptosis and prevented the decrease in focal adhesion proteins.

Conclusions:

• Focal adhesion proteins (vinculin, paxillin, FAK) are degraded during the cell rounding associated with apoptosis.
• This proteolysis may disrupt cell adhesion and survival signaling, playing a key role in apoptosis initiation and execution.
• Targeting focal adhesion protein degradation could be a strategy in cancer therapy.